Professor, Internal Medicine, Eastern Virginia Medical School
Infectious Disease
Dr. Edward C. Oldfield, MD
|
|
Give Review
Edward Oldfield works in the field of Infectious Disease. He graduated from University of Virginia School of Medicine. He received awards:"Meaningful Use Stage 1 Certification" and "Top MD". Edward C. Oldfield, MD is a published doctor. He published 48 publications, including: 'Computed Tomography Colonography: Ready for Prime Time for Colon Cancer Screening?'
Publications
- Computed Tomography Colonography: Ready for Prime Time for Colon Cancer Screening?
- Treatment of gastroesophageal reflux disease: two new oral formulations dexlansoprazole MR and esomezol (esomeprazole strontium).
- Recalcitrant herpetic scrotal ulcer as a manifestation of immune reconstitution inflammatory syndrome.
- Electronic medical records: unintended consequences of a duplicitous default setting.
- Infectious disease. Early loss of immune cells and progressive immunodeficiency in HIV infection: it's all about the gut.
- Diarrhea. Best option for traveler's diarrhea: loperamide plus an antibiotic?
- Diarrhea. Enterotoxigenic Bacteroides fragilis: newly recognized cause of inflammatory diarrhea.
- Diarrhea--cryptosporidial diarrhea in patients with AIDS: impressive results with Rifaximin.
- Diarrhea - novel transdermal patch vaccine to prevent travelers' diarrhea.
- Gastrointestinal cytomegalovirus disease in the immunocompromised patient.
- Infectious disease. Endocarditis prophylaxis: new guideline, much less antibiotic prophylaxis.
- Infectious disease. The nose knows.
- Use of a rifaximin "chaser" in the treatment of recurrent Clostridium difficile-associated diarrhea.
- A new one-two punch against traveller's diarrhea: azithromycin plus loperamide.
- Infectious disease. Probiotics for the prevention of diarrhea associated with antibiotics.
- Infectious disease. Vancomycin should be the drug of choice for severe Clostridium difficile-associated diarrhea.
- The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
- Most common cause of community-based diarrhea: EAEC.
- PIs and PPIs: protease inhibitors and proton pump inhibitors.
- Clostridium difficile-negative antibiotic-associated hemorrhagic colitis: the role of cytotoxin-producing Klebsiella oxytoca.
- Empiric treatment of traveler's diarrhea: azithromycin emerging as new drug of choice?
- Infectious disease. Failures of antibiotic prophylaxis for travelers' diarrhea: norovirus may be the culprit.
- Clostridium difficile-associated diarrhea: resurgence with a vengeance.
- Rifaximin: a non-absorbable antibiotic for prevention of travelers' diarrhea.
- Clostridium difficile: more and meaner.
- Clostridium difficile: What to do? Less responsive to treatment, more relapses.
- Another immunoproliferative gastrointestinal condition responsive to antibiotics.
- Antibiotic prophylaxis in severe acute pancreatitis: the never-ending controversy.
- Intestinal pseudomembranes: Staphylococcus aureus or Clostridium difficile or both?
- Tinidazole: a new super-charged metronidazole.
- New issues in infectious diarrhea.
- "It lacked aesthetic appeal." So what? It worked.
- No mercy from MRSA.
- Updated guidelines for reprocessing gastrointestinal endoscopies.
- Promising power against parasites.
- Rifaximin: a nonabsorbable antibiotic for travelers' diarrhea.
- Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
- New guidelines for treatment of complicated intra-abdominal infections.
- Antibiotic-associated diarrhea: it's all about the butyrate.
- Direct detection of Shiga toxin: a necessary step for improved diagnosis of enterohemorrhagic colitis.
- The agony and the ecstasy.
- The road to resistance: antibiotics as growth promoters for animals.
- Another reason to use quinolones for traveler's diarrhea.
- Chronic diarrhea, HIV, and honeybees.
- Stool cultures for nosocomial diarrhea: money down the drain?
- Evaluation of chronic diarrhea in patients with human immunodeficiency virus infection.
- Progressive outer retinal necrosis: a missed diagnosis and a blind, young woman.
Schools
University of Virginia Main Campus
Naval Regl Med Center
National Naval Med Center
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Top MD
Education
-
National Capital Consortium -
Naval Medical Center -
University of Virginia School of Medicine
Drug Facts
| NPI NUMBER | 1114993573 | |
| NPPES Provider LastName | OLDFIELD | |
| NPPES Provider FirstName | EDWARD | |
| NPPES Provider ZIPCode | 235071914 | |
| NPPES Provider State | VA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 1100.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114993573 |
| Last Name Of The Provider | OLDFIELD |
| First Name Of The Provider | EDWARD |
| View All |
Similar Doctors
|
|
Dr. Aarti Agrawal, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward E. Wing, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Billy B. Richmond Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martha L. Mooney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geraldine A. Stott, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony Larocco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine J. Derber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Freshta Jaghori, MD
This Doctor is OpenDoctor Recommended.
|